barriers to care lead to profitable platforms by compounding meds, by-pass geography/time w/ asynchronous providers, self-pace edu vids, no prior auth & shortage, FSA/HSA eligible pay plans. I wish we invest in primary care having less barriers and time/resources to do this care instead
Reposted from Jonathan Jarry
I remember criticizing Hims in the beginning for selling pseudoscientific remedies (but also proven drugs, to be clear).

Now, they're selling "compounded semaglutide."

Would love to hear from experts on this. Big Super Bowl campaign in the works for this. Cc Medsky

www.hims.com

Comments